A study finds that male science students have higher opinions of their abilities than female students earning the same grade, the New York Times reports.
In PLOS this week: ramifications of sexual recombination in bacteria, Mycobacterium leprae genome sequences, and more.
The Biomedical Advanced Research and Development Authority aims to produce at least two US Food and Drug Administration-cleared tests.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.
The researchers also found fixed variants in the tortoise genome linked to the immune system, which may help manage the health of the threatened species.
New data from Peregrine Pharmaceuticals, along with other recent research, suggests that surface proteins can be used to isolate cancer-specific exosomes to detect the presence of a tumor.
Researchers showed it could differentiate pancreatic cancer cases from controls with high sensitivity, and believe it could work similarly for other cancers or in infectious disease.
Robert Cook-Deegan and Subhashini Chandrasekharan discuss genetic testing patents in the New England Journal of Medicine.
The funding is part of the NHGRI Genome Technology Program, which promotes new methods, technology, and instruments for sequencing and functional genomics.
A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.
Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.
In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.
A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.